首页> 外文期刊>Medicine. >The effectiveness and safety of recombinant human growth hormone combined with alginate dressing in the treatment of diabetic foot ulcer
【24h】

The effectiveness and safety of recombinant human growth hormone combined with alginate dressing in the treatment of diabetic foot ulcer

机译:重组人体生长激素与海藻酸盐敷料治疗糖尿病足溃疡治疗的有效性和安全性

获取原文
           

摘要

Diabetes isa group ofmetabolic diseasescharacterized by high blood sugarand itcauses by insulin secretion or deficiency ofaction, or both. Diabetes is becoming a public health problemas theimprovement of people's living standardsand thechanges oftheir lifestyles. [1] Globally, the number of people with diabetes is reported to havereached 382 million in 2013,and that number willexceed 592 million by 2035. With a prevalencerate of 9.7%, China has becomethefastest growing region of diabetes in the world and the world's largest diabetescountry. [2,3] The harmof diabetes is mainly reflected in complications, it has reported that therisk ofcardiovascularcomplications in diabetic patients is 2 to 4 times higher than that in normal people,and diabetes is theleading cause of non-traumaticamputation, blindness,and advanced kidney disease. [4,5] As one oftheseriouscomplications of diabetes, diabeticfoot ulcer (DFU), its high incidence, high hospitalization rateand high disability rateseriously threaten the quality oflife of diabetic patients. According to statistics, diabetic patients havea 12%to 25%chance of developingDFU,and the recurrencerate within 5 yearsafter ulcer healing is 50%to 70%. [6] Abouta quarter of people hospitalized with diabetesareassociated withDFU complications,and thereis 1 amputation dueto DFUevery 30 seconds in the world hasa 50%increased risk oflosing another leg after 3 years, theleading cause of non-traumaamputation, with a death rate of 13%to 17%. [7,8] DFUnot only affects the quality oflife of diabetic patients, but also bringsa heavy burden to their familiesand society. In the United States, thetotalcost oftreating afinalamputation dueto asevere DFU infection isalready as high as $190,000; inChina, thecost oftreating non-severe DFUis $1673; in India,a patient's totalincome of 5.7 yearscan only treatafoot ulcer surface. [9] Itcan beseen that DFUhas becomea publicchallenge, the developmentand prognosis offoot ulcer is theresult ofmulti-factor interaction,and it isclosely related to neurological dysfunction,exovascular lesions,and infection. It is necessary to study thecauses offoot ulcer healing and perfect its treatment plan to exploreeffectiveearly prevention and treatmentmethods.
机译:糖尿病ISA组由高血糖患者由高血糖患者进行胰岛素分泌或缺乏作用,或两者。糖尿病正成为公共卫生问题,人们的生活水平的过程和生活方式的学生。 [1]在全球范围内,据报道,2013年患有38200万人的人数为3.82亿,并在2035年之前。普遍存在的9.7%,中国已经成为世界上最大的糖尿病地区和世界上最大的糖尿病地区Diabetescountry。 [2,3]糖尿病的伤害主要反映在并发症中,据报道,糖尿病患者的心电图障碍患者的夜间血管扣容比正常人群高出2至4倍,糖尿病是非创伤性,失明和晚期肾脏的原因疾病。 [4,5]作为糖尿病患者的统一价值,糖尿病患者(DFU),其高发病率,高住院病率高的残疾威胁地威胁着糖尿病患者的品质。根据统计数据,糖尿病患者Havea 25%〜25%的发展利润的几率,5年内溃疡愈合内的复发为50%至70%。 [6]大约四分之一的人住院治疗糖尿病患者的糖尿病并发症,其中1次截肢二十秒,在世界上30秒,3年后,举行的另一腿的风险增加了50%,不创造的非创伤原因,死亡率为13%到17%。 [7,8] Dfunot只影响糖尿病患者的生活质量,而且对他们的家庭和社会带来了沉重的负担。在美国,TheToTalcosting AfinAlamputute Dueto Asevere DFU感染是高达190,000美元;仁那,Thecost ofTreating非严重DFUIS $ 1673;在印度,患者的总计5.7年的TypeCan只能治疗溃疡表面。 [9] ITCAN BEASEN那个DFUHAS成为培训,预后溃疡的发育和预后都是多因素的相互作用,它与神经功能障碍,外血管病变和感染是无疑的。有必要研究遗漏溃疡治疗,并完善其治疗计划,以探索缺少和治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号